Catalyst Wire Dossier Catalyst Wire Dossier

Anavip

F(ab')2 antivenom · Instituto Bioclon S.A. de C.V.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anavip, covering 2009-03-24 to 2012-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip. [Phase 3]

See pricing